Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017

Abstract Background The point prevalence survey of healthcare-associated infections (HAIs) and antimicrobial use organized by the European Centre for Disease Prevention and Control (ECDC-PPS) and the Global Point Prevalence Survey of antimicrobial consumption (Global-PPS) were simultaneously perform...

Full description

Bibliographic Details
Main Authors: Eline Vandael, Katrien Latour, Herman Goossens, Koen Magerman, Nico Drapier, Boudewijn Catry, Ann Versporten, the Belgian Point Prevalence Survey Study Group
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Antimicrobial Resistance and Infection Control
Subjects:
Online Access:https://doi.org/10.1186/s13756-019-0663-7
id doaj-a41bfe28cd8541b8840fbb0af6423db5
record_format Article
spelling doaj-a41bfe28cd8541b8840fbb0af6423db52021-01-17T12:03:28ZengBMCAntimicrobial Resistance and Infection Control2047-29942020-01-019111310.1186/s13756-019-0663-7Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017Eline Vandael0Katrien Latour1Herman Goossens2Koen Magerman3Nico Drapier4Boudewijn Catry5Ann Versporten6the Belgian Point Prevalence Survey Study GroupHealthcare-associated infections and antimicrobial resistance, SciensanoHealthcare-associated infections and antimicrobial resistance, SciensanoLaboratory of Medical Microbiology, University of AntwerpBelgian Antibiotic Policy Coordination Commission (BAPCOC), Direction General Healthcare, Federal Public Service Health, Food Chain Safety and EnvironmentLaboratory of Medical Microbiology, University of AntwerpHealthcare-associated infections and antimicrobial resistance, SciensanoLaboratory of Medical Microbiology, University of AntwerpAbstract Background The point prevalence survey of healthcare-associated infections (HAIs) and antimicrobial use organized by the European Centre for Disease Prevention and Control (ECDC-PPS) and the Global Point Prevalence Survey of antimicrobial consumption (Global-PPS) were simultaneously performed in Belgian acute care hospitals in 2017. Methods Belgian acute care hospitals were invited to participate in either the ECDC or Global-PPS. Hospital/ward/patient-level data were collected between September–December 2017. All patients present in the wards at 8 a.m. on the day of the PPS were included. The data of the ECDC and Global-PPS on antimicrobial consumption were pooled. Detailed data on HAIs were analysed for ECDC-PPS. Results Overall, 110 Belgian acute care hospital sites participated in the ECDC and Global-PPS (countrywide participation rate: 81.4%, 28,007 patients). Overall, a crude prevalence of patients with at least one antimicrobial of 27.1% (95% confidence interval (CI) 26.5–27.6%) was found. The most frequently reported indications were pneumonia (23.2%), urinary tract infections (15.2%) and skin and soft tissue infections (11.9%). The reason for antimicrobial use was recorded for 81.9% of the prescriptions, a stop/review date for 40.8% and compliance with local antibiotic guidelines for 76.6%. In the ECDC-PPS, the crude prevalence of patients with at least one HAI was 7.3% (95%CI 6.8–7.7%). Most frequently reported HAIs were pneumonia (21.6%) and urinary tract infections (21.3%). Conclusions HAI and antimicrobial use prevalence remained stable in comparison with the previous PPS (7.1% and 27.4% in 2011 and 2015, respectively). Belgian hospitals should be further stimulated to set local targets to improve antibiotic prescribing and reduce HAI.https://doi.org/10.1186/s13756-019-0663-7Point prevalence surveyAntimicrobial consumptionHealthcare-associated infectionsBelgiumAcute care hospitals
collection DOAJ
language English
format Article
sources DOAJ
author Eline Vandael
Katrien Latour
Herman Goossens
Koen Magerman
Nico Drapier
Boudewijn Catry
Ann Versporten
the Belgian Point Prevalence Survey Study Group
spellingShingle Eline Vandael
Katrien Latour
Herman Goossens
Koen Magerman
Nico Drapier
Boudewijn Catry
Ann Versporten
the Belgian Point Prevalence Survey Study Group
Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017
Antimicrobial Resistance and Infection Control
Point prevalence survey
Antimicrobial consumption
Healthcare-associated infections
Belgium
Acute care hospitals
author_facet Eline Vandael
Katrien Latour
Herman Goossens
Koen Magerman
Nico Drapier
Boudewijn Catry
Ann Versporten
the Belgian Point Prevalence Survey Study Group
author_sort Eline Vandael
title Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017
title_short Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017
title_full Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017
title_fullStr Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017
title_full_unstemmed Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017
title_sort point prevalence survey of antimicrobial use and healthcare-associated infections in belgian acute care hospitals: results of the global-pps and ecdc-pps 2017
publisher BMC
series Antimicrobial Resistance and Infection Control
issn 2047-2994
publishDate 2020-01-01
description Abstract Background The point prevalence survey of healthcare-associated infections (HAIs) and antimicrobial use organized by the European Centre for Disease Prevention and Control (ECDC-PPS) and the Global Point Prevalence Survey of antimicrobial consumption (Global-PPS) were simultaneously performed in Belgian acute care hospitals in 2017. Methods Belgian acute care hospitals were invited to participate in either the ECDC or Global-PPS. Hospital/ward/patient-level data were collected between September–December 2017. All patients present in the wards at 8 a.m. on the day of the PPS were included. The data of the ECDC and Global-PPS on antimicrobial consumption were pooled. Detailed data on HAIs were analysed for ECDC-PPS. Results Overall, 110 Belgian acute care hospital sites participated in the ECDC and Global-PPS (countrywide participation rate: 81.4%, 28,007 patients). Overall, a crude prevalence of patients with at least one antimicrobial of 27.1% (95% confidence interval (CI) 26.5–27.6%) was found. The most frequently reported indications were pneumonia (23.2%), urinary tract infections (15.2%) and skin and soft tissue infections (11.9%). The reason for antimicrobial use was recorded for 81.9% of the prescriptions, a stop/review date for 40.8% and compliance with local antibiotic guidelines for 76.6%. In the ECDC-PPS, the crude prevalence of patients with at least one HAI was 7.3% (95%CI 6.8–7.7%). Most frequently reported HAIs were pneumonia (21.6%) and urinary tract infections (21.3%). Conclusions HAI and antimicrobial use prevalence remained stable in comparison with the previous PPS (7.1% and 27.4% in 2011 and 2015, respectively). Belgian hospitals should be further stimulated to set local targets to improve antibiotic prescribing and reduce HAI.
topic Point prevalence survey
Antimicrobial consumption
Healthcare-associated infections
Belgium
Acute care hospitals
url https://doi.org/10.1186/s13756-019-0663-7
work_keys_str_mv AT elinevandael pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017
AT katrienlatour pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017
AT hermangoossens pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017
AT koenmagerman pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017
AT nicodrapier pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017
AT boudewijncatry pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017
AT annversporten pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017
AT thebelgianpointprevalencesurveystudygroup pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017
_version_ 1724335515582332928